FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2611117534> ?p ?o ?g. }

• W2611117534 endingPage "101042831769223" @default.
• W2611117534 startingPage "101042831769223" @default.
• W2611117534 abstract "Since the incidence of breast cancer increases dramatically all over the world, the search for effective treatment is an urgent need. Metformin has demonstrated anti-tumorigenic effect both in vivo and in vitro in different cancer types. This work was designed to examine on molecular level the mode of action of metformin in mice bearing solid Ehrlich carcinoma and to evaluate the use of metformin in conjunction with doxorubicin as a combined therapy against solid Ehrlich carcinoma. Ehrlich ascites carcinoma cells were inoculated in 60 female mice as a model of breast cancer. The mice were divided into four equal groups: Control tumor, metformin, doxorubicin, and co-treatment. Metformin (15 mg/kg) and doxorubicin (4 mg/kg) were given intraperitoneally (i.p.) for four cycles every 5 days starting on day 12 of inoculation. The anti-tumorigenic effect of metformin was mediated by enhancement of adenosine monophosphate protein kinase activity and elevation of P53 protein as well as the suppression of nuclear factor-kappa B, DNA contents, and cyclin D1 gene expression. Metformin and doxorubicin mono-treatments exhibited opposing action regarding cyclin D1 gene expression, phosphorylated adenosine monophosphate protein kinase, and nuclear factor-kappa B levels. Co-treatment markedly decreased tumor volume, increased survival rate, and improved other parameters compared to doxorubicin group. In parallel, the histopathological findings demonstrated enhanced apoptosis and absence of necrosis in tumor tissue of co-treatment group. Metformin proved chemotherapeutic effect which could be mediated by the activation of adenosine monophosphate protein kinase and related pathways. Combining metformin and doxorubicin, which exhibited different mechanisms of action, produced greater efficacy as anticancer therapeutic regimen." @default.
• W2611117534 created "2017-05-12" @default.
• W2611117534 creator A5007382115 @default.
• W2611117534 creator A5038453678 @default.
• W2611117534 creator A5079045771 @default.
• W2611117534 creator A5088097473 @default.
• W2611117534 date "2017-05-01" @default.
• W2611117534 modified "2023-09-23" @default.
• W2611117534 title "Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway" @default.
• W2611117534 cites W1487922930 @default.
• W2611117534 cites W1538710488 @default.
• W2611117534 cites W1968351069 @default.
• W2611117534 cites W1998891209 @default.
• W2611117534 cites W2011239505 @default.
• W2611117534 cites W2015171350 @default.
• W2611117534 cites W2016752484 @default.
• W2611117534 cites W2017168362 @default.
• W2611117534 cites W2023560061 @default.
• W2611117534 cites W2042008937 @default.
• W2611117534 cites W2050865113 @default.
• W2611117534 cites W2056142361 @default.
• W2611117534 cites W2056161011 @default.
• W2611117534 cites W2066700651 @default.
• W2611117534 cites W2067979493 @default.
• W2611117534 cites W2068303903 @default.
• W2611117534 cites W2072140679 @default.
• W2611117534 cites W2075604285 @default.
• W2611117534 cites W2088896738 @default.
• W2611117534 cites W2089655089 @default.
• W2611117534 cites W2091727117 @default.
• W2611117534 cites W2101425508 @default.
• W2611117534 cites W2102836293 @default.
• W2611117534 cites W2115957809 @default.
• W2611117534 cites W2117692326 @default.
• W2611117534 cites W2125292576 @default.
• W2611117534 cites W2129379848 @default.
• W2611117534 cites W2134266104 @default.
• W2611117534 cites W2140204893 @default.
• W2611117534 cites W2146893766 @default.
• W2611117534 cites W2153980878 @default.
• W2611117534 cites W2159044625 @default.
• W2611117534 cites W2160615487 @default.
• W2611117534 cites W2161045640 @default.
• W2611117534 cites W2170374398 @default.
• W2611117534 cites W2171979623 @default.
• W2611117534 cites W2171998898 @default.
• W2611117534 cites W2192294917 @default.
• W2611117534 cites W2217747537 @default.
• W2611117534 cites W2226084991 @default.
• W2611117534 cites W2296560872 @default.
• W2611117534 cites W2317055602 @default.
• W2611117534 cites W2334351103 @default.
• W2611117534 cites W2346731202 @default.
• W2611117534 cites W2419620437 @default.
• W2611117534 cites W822532126 @default.
• W2611117534 doi "https://doi.org/10.1177/1010428317692235" @default.
• W2611117534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28459206" @default.
• W2611117534 hasPublicationYear "2017" @default.
• W2611117534 type Work @default.
• W2611117534 sameAs 2611117534 @default.
• W2611117534 citedByCount "29" @default.
• W2611117534 countsByYear W26111175342018 @default.
• W2611117534 countsByYear W26111175342019 @default.
• W2611117534 countsByYear W26111175342020 @default.
• W2611117534 countsByYear W26111175342021 @default.
• W2611117534 countsByYear W26111175342022 @default.
• W2611117534 countsByYear W26111175342023 @default.
• W2611117534 crossrefType "journal-article" @default.
• W2611117534 hasAuthorship W2611117534A5007382115 @default.
• W2611117534 hasAuthorship W2611117534A5038453678 @default.
• W2611117534 hasAuthorship W2611117534A5079045771 @default.
• W2611117534 hasAuthorship W2611117534A5088097473 @default.
• W2611117534 hasBestOaLocation W26111175341 @default.
• W2611117534 hasConcept C121608353 @default.
• W2611117534 hasConcept C126322002 @default.
• W2611117534 hasConcept C134018914 @default.
• W2611117534 hasConcept C184235292 @default.
• W2611117534 hasConcept C199835354 @default.
• W2611117534 hasConcept C2776694085 @default.
• W2611117534 hasConcept C2776991684 @default.
• W2611117534 hasConcept C2780323712 @default.
• W2611117534 hasConcept C2781303535 @default.
• W2611117534 hasConcept C29537977 @default.
• W2611117534 hasConcept C502942594 @default.
• W2611117534 hasConcept C55493867 @default.
• W2611117534 hasConcept C555293320 @default.
• W2611117534 hasConcept C71924100 @default.
• W2611117534 hasConcept C86803240 @default.
• W2611117534 hasConcept C97029542 @default.
• W2611117534 hasConcept C98274493 @default.
• W2611117534 hasConceptScore W2611117534C121608353 @default.
• W2611117534 hasConceptScore W2611117534C126322002 @default.
• W2611117534 hasConceptScore W2611117534C134018914 @default.
• W2611117534 hasConceptScore W2611117534C184235292 @default.
• W2611117534 hasConceptScore W2611117534C199835354 @default.
• W2611117534 hasConceptScore W2611117534C2776694085 @default.
• W2611117534 hasConceptScore W2611117534C2776991684 @default.
• W2611117534 hasConceptScore W2611117534C2780323712 @default.

• next